Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients

This study has been completed.

Study NCT00904371 Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: May 18, 2009 Last Updated: April 8, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	January 2011 (Final data collection date for primary outcome measure)